LONDON–(BUSINESS WIRE)–The global mass spectrometry market size is expected to grow by USD 2.17 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of over 7%. Request free sample pages
Read the 120-page report with TOC on “Mass Spectrometry Market Analysis Report by End-user (Pharmaceutical and biotechnology industries, Chemical and petrochemical industries, and Others) and Geographic Landscape (North America, APAC, Europe, South America, and MEA), and the Segment Forecasts, 2020-2024”.
The market is driven by the rising focus on drug discovery and development. In addition, the increase in use of hyphenated technology is anticipated to boost the mass spectrometry market growth.
Factors such as high blood pressure, high blood cholesterol, obesity, lack of physical activity, unhealthy diet, and tobacco use can lead to major chronic diseases such as CVDs, cancer, chronic obstructive pulmonary disease, and type 2 diabetes. The rise in the prevalence of several chronic diseases around the world is encouraging pharmaceutical and biotechnology companies as well as research institutes to focus on drug discovery and development. This has increased R&D spending in the pharmaceutical industry for drug…